MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA. (12th June 2019) - Ruan, J.; Leonard, J.P.; Coleman, M.; Rutherford, S.; Van Besien, K.; Rodriguez, A.; Benderoff, L.; Mehta‐Shah, N.; Moskowitz, A.; Sokol, L.; Cerchietti, L.; Inghirami, G.; et al.